0,807  0,010  Caspase 9 stimulant
0,790  0,018  Apoptosis agonist
0,712  0,017  Antineoplastic (lung cancer)
0,682  0,010  Antineoplastic (ovarian cancer)
0,651  0,027  Antineoplastic (breast cancer)
0,601  0,011  Antineoplastic (pancreatic cancer)
0,590  0,016  Sensitization
0,618  0,049  Antiinflammatory
0,581  0,014  Antipruritic, allergic
0,575  0,015  Chemopreventive
0,564  0,014  UGT1A9 substrate
0,526  0,017  Antipsoriatic
0,518  0,018  AR expression inhibitor
0,516  0,018  Lipoprotein disorders treatment
0,506  0,009  UGT1A4 substrate
0,505  0,010  Antineoplastic (endocrine cancer)
0,524  0,032  Antineoplastic (colorectal cancer)
0,500  0,010  UGT1A1 substrate
0,525  0,035  Antileukemic
0,517  0,031  Antineoplastic (colon cancer)
0,490  0,007  UGT1A3 substrate
0,470  0,004  Antiinfertility, female
0,488  0,025  Antineoplastic (melanoma)
0,467  0,006  Antiacne
0,501  0,046  TNF expression inhibitor
0,468  0,015  Hypolipemic
0,461  0,008  Contraceptive
0,477  0,024  Chemoprotective
0,476  0,031  CYP2C19 substrate
0,442  0,006  Antipruritic, non-allergic
0,458  0,028  Antineoplastic (cervical cancer)
0,465  0,039  Prostate cancer treatment
0,429  0,004  ABCA1 expression enhancer
0,457  0,032  Antihypercholesterolemic
0,451  0,031  Hepatic disorders treatment
0,424  0,009  Prostate disorders treatment
0,433  0,023  UGT2B4 substrate
0,414  0,010  UGT2B7 substrate
0,433  0,030  Antineoplastic (glioma)
0,416  0,022  UGT1A6 substrate
0,442  0,050  CYP2C9 substrate
0,407  0,025  Nitric oxide antagonist
0,404  0,030  Cardiovascular analeptic
0,386  0,013  Melanin inhibitor
0,397  0,025  Antihypoxic
0,384  0,012  Interferon gamma antagonist
0,407  0,035  Cytotoxic
0,400  0,032  NOS2 expression inhibitor
0,413  0,053  Ulceration
0,373  0,014  Prostatic (benign) hyperplasia treatment
0,393  0,036  Antioxidant
0,380  0,024  Sodium/bile acid cotransporter inhibitor
0,410  0,060  CYP3A4 substrate
0,417  0,067  Histamine release inhibitor
0,329  0,005  LDLR expression enhancer
0,354  0,032  Vascular (periferal) disease treatment
0,387  0,067  Transcription factor NF kappa B inhibitor
0,351  0,033  Antineoplastic (liver cancer)
0,329  0,014  UGT2B15 substrate
0,403  0,089  Antidiabetic
0,403  0,089  Cyclophilin D inhibitor
0,384  0,071  CYP2C19 inhibitor
0,313  0,017  Protein-tyrosine phosphatase inhibitor
0,347  0,052  Teratogen
0,350  0,056  Apoptosis antagonist
0,354  0,059  Antifungal
0,302  0,010  UGT2B9 substrate
0,316  0,026  Antiviral (Influenza)
0,316  0,026  P-glycoprotein inhibitor
0,344  0,054  Calcium channel activator
0,347  0,060  Caspase 3 stimulant
0,331  0,045  Antiprotozoal (Leishmania)
0,295  0,017  Antiviral (Influenza A)
0,325  0,054  Hypoxia-inducible factor 1 alpha inhibitor
0,338  0,069  Cholesterol antagonist
0,354  0,085  Immunosuppressant
0,290  0,022  Hair growth stimulant
0,281  0,012  Protein-tyrosine phosphatase 1B inhibitor
0,315  0,056  Embryotoxic
0,309  0,050  Free radical scavenger
0,361  0,106  5 Hydroxytryptamine release inhibitor
0,277  0,025  Neurotrophic factor enhancer
0,275  0,026  Lipocortins synthesis antagonist
0,315  0,067  NOS3 expression inhibitor
0,285  0,038  UDP-glucuronosyltransferase substrate
0,276  0,034  Non-steroidal antiinflammatory agent
0,283  0,043  Antihypertriglyceridemic
0,294  0,054  Proliferative diseases treatment
0,284  0,049  Antineoplastic (sarcoma)
0,309  0,077  CYP2D6 substrate
0,292  0,060  Cardiotonic
0,250  0,021  Heat shock protein 90 antagonist
0,303  0,075  Respiratory analeptic
0,230  0,004  CDC25B inhibitor
0,241  0,016  UGT2B10 substrate
0,267  0,043  Abortion inducer
0,227  0,010  Contraceptive female
0,214  0,005  CDC25A inhibitor
0,250  0,043  Hepatoprotectant
0,220  0,014  SULT1A1 substrate
0,280  0,078  Antineoplastic (multiple myeloma)
0,254  0,053  Antineoplastic enhancer
0,250  0,050  Anesthetic general
0,204  0,004  Purinergic P2X2 antagonist
0,229  0,033  Anesthetic
0,208  0,013  Androgen antagonist
0,310  0,115  Atherosclerosis treatment
0,260  0,073  Antineoplastic (non-small cell lung cancer)
0,192  0,009  Keratolytic
0,243  0,062  Antimitotic
0,215  0,037  Protein kinase stimulant
0,215  0,037  VEGF expression inhibitor
0,235  0,059  RNA-directed DNA polymerase inhibitor
0,282  0,106  Vasodilator, peripheral
0,263  0,090  Cardioprotectant
0,186  0,014  TRPA1 agonist
0,268  0,095  Analeptic
0,203  0,030  Arachidonic acid antagonist
0,184  0,012  Actinic keratosis treatment
0,199  0,027  Cholesterol synthesis inhibitor
0,176  0,005  3C-Like protease (SARS coronavirus) inhibitor
0,246  0,076  Tumour necrosis factor alpha release inhibitor
0,247  0,078  Antipyretic
0,215  0,049  Antimutagenic
0,253  0,088  Antidiabetic (type 2)
0,257  0,093  CYP1A2 substrate
0,197  0,033  Antifungal enhancer
0,167  0,005  Acetyl-CoA transferase inhibitor
0,229  0,070  Antineoplastic (glioblastoma multiforme)
0,161  0,003  Retinoid X beta receptor agonist
0,156  0,003  Retinoid X alpha receptor agonist
0,154  0,002  Retinoid X gamma receptor agonist
0,256  0,105  12-Lipoxygenase inhibitor
0,170  0,019  Dementia treatment
0,177  0,028  Adenylate cyclase stimulant
0,240  0,091  Gastrin inhibitor
0,172  0,024  Pregnane X receptor agonist
0,256  0,111  Antineoplastic (osteosarcoma)
0,210  0,064  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,261  0,116  ICAM1 expression inhibitor
0,164  0,019  Vascular dementia treatment
0,191  0,046  Interleukin 6 antagonist
0,155  0,014  Antiviral (SARS coronavirus)
0,155  0,014  Antiviral (Coronavirus)
0,141  0,003  Retinoid X receptor agonist
0,188  0,049  Phospholipase A2 inhibitor
0,215  0,077  Antiparasitic
0,162  0,024  HDL-cholesterol increasing
0,229  0,094  DNA damaging
0,183  0,049  Lipid peroxidase inhibitor
0,178  0,045  Tubulin antagonist
0,137  0,003  Retinoic acid receptor agonist
0,136  0,003  Retinoic acid alpha receptor agonist
0,234  0,102  Radioprotector
0,159  0,029  Choleretic
0,187  0,057  Antihelmintic (Nematodes)
0,215  0,087  Angiogenesis stimulant
0,141  0,014  Aromatase inhibitor
0,165  0,040  Antieczematic
0,171  0,047  SULT1A3 substrate
0,142  0,019  UGT2B11 substrate
0,138  0,015  Ornithine decarboxylase inhibitor
0,161  0,038  Antihemorrhagic
0,129  0,007  Progesterone antagonist
0,288  0,168  Calcium channel L-type activator
0,161  0,041  Farnesoid X receptor antagonist
0,213  0,098  Aldehyde oxidase inhibitor
0,116  0,002  Retinoic acid alpha receptor antagonist
0,116  0,005  Heme oxygenase stimulant
0,182  0,070  Male reproductive disfunction treatment
0,142  0,032  Sulfotransferase substrate
0,124  0,014  Hyperparathyroidism treatment
0,122  0,013  SULT1A2 substrate
0,149  0,040  Vanilloid 1 agonist
0,111  0,002  Retinoic acid beta receptor antagonist
0,108  0,002  Retinoic acid receptor antagonist
0,151  0,047  Cyclooxygenase 3 inhibitor
0,184  0,081  Sedative
0,154  0,051  Antiseptic
0,217  0,114  Transcription factor STAT3 inhibitor
0,137  0,035  UGT2B1 substrate
0,118  0,017  Potassium channel large-conductance Ca-activated activator
0,172  0,072  Sigma receptor agonist
0,106  0,007  Potassium channel Kv1.3 blocker
0,103  0,005  Liver X receptor alpha agonist
0,101  0,002  Retinoic acid receptor gamma antagonist
0,116  0,020  Vanilloid agonist
0,117  0,024  Glutamate release inhibitor
0,095  0,003  Alpha 1L adrenoreceptor agonist
0,195  0,103  Antiamyloidogenic
0,106  0,015  Anticholelithogenic
0,248  0,158  Antiobesity
0,146  0,057  Skin whitener
0,226  0,137  CTGF expression inhibitor
0,094  0,007  Calcium channel P-type blocker
0,088  0,003  Retinoic acid beta receptor agonist
0,161  0,076  Heat shock protein 90 alpha antagonist
0,143  0,060  Acetylcholinesterase inhibitor
0,248  0,166  15-Lipoxygenase inhibitor
0,110  0,029  Tocolytic
0,121  0,041  Potassium channel (Ca-activated) activator
0,222  0,143  Thyroid hormone antagonist
0,168  0,090  Antihelmintic
0,122  0,045  Butyrylcholinesterase inhibitor
0,079  0,003  Retinoid X receptor antagonist
0,151  0,077  Diuretic
0,127  0,053  Microtubule formation inhibitor
0,193  0,119  Hypoglycemic
0,237  0,164  Antineoplastic (small cell lung cancer)
0,214  0,141  Bone diseases treatment
0,183  0,110  Antineoplastic (lymphoma)
0,073  0,002  Retinoid X gamma receptor antagonist
0,103  0,034  Inducible nitric-oxide synthase inhibitor
0,073  0,006  Acetyl-CoA transferase 1 inhibitor
0,179  0,112  Antiglaucomic
0,117  0,051  Electron transport complex I inhibitor
0,092  0,026  Glycine receptor agonist
0,070  0,004  Cholesterol ester transfer protein antagonist
0,068  0,003  Retinoid X alpha receptor antagonist
0,195  0,131  Antiosteoporotic
0,158  0,094  Antineoplastic (gastric cancer)
0,083  0,019  Transcription factor AP-1 inhibitor
0,076  0,013  Mineralocorticoid receptor antagonist
0,179  0,117  Antineoplastic (lymphocytic leukemia)
0,064  0,003  Retinoic acid gamma receptor agonist
0,074  0,013  5-Alpha-reductase inhibitor
0,126  0,065  Coagulant
0,069  0,009  Glucocorticoid antagonist
0,189  0,129  Spasmolytic
0,113  0,053  Nav1.1 sodium channel blocker
0,199  0,141  Lipoxygenase inhibitor
0,059  0,002  Retinoid X beta receptor antagonist
0,179  0,123  Age-related macular degeneration treatment
0,176  0,122  VCAM1 expression inhibitor
0,209  0,156  Antineoplastic (brain cancer)
0,126  0,073  Retinoprotector
0,066  0,014  Liver X receptor agonist
0,067  0,015  Aldosterone antagonist
0,106  0,055  Anabolic
0,090  0,041  Na+ K+ transporting ATPase inhibitor
0,122  0,076  Antihyperlipoproteinemic
0,266  0,221  Antineoplastic (solid tumors)
0,091  0,047  GABA A receptor agonist
0,093  0,049  Antineoplastic antibiotic
0,159  0,116  CYP2B6 inhibitor
0,062  0,020  Alpha 1L adrenoreceptor antagonist
0,066  0,025  Postcoital contraceptive
0,151  0,110  Succinate dehydrogenase inhibitor
0,064  0,024  Acetyl-CoA transferase 2 inhibitor
0,125  0,086  Antineoplastic (squamous cell carcinoma)
0,108  0,069  GABA receptor agonist
0,048  0,011  Liver X receptor beta agonist
0,144  0,108  Tumour necrosis factor antagonist
0,109  0,076  Estrogen antagonist
0,145  0,112  Amyloid beta aggregation inhibitor
0,063  0,030  Lipocortins synthesis agonist
0,094  0,062  Bile acid receptor antagonist
0,188  0,156  Transcription factor STAT inhibitor
0,108  0,076  Anesthetic local
0,122  0,091  Antiparkinsonian, tremor relieving
0,086  0,056  mTOR complex 2 inhibitor
0,039  0,010  Liver X receptor alpha antagonist
0,064  0,035  Heat shock protein 90 beta antagonist
0,037  0,008  Follicle-stimulating hormone agonist
0,149  0,121  Phobic disorders treatment
0,065  0,038  Antimycoplasmal
0,109  0,083  Growth stimulant
0,097  0,071  Estrogen receptor beta antagonist
0,118  0,093  Antineoplastic (uterine cancer)
0,203  0,179  Vasodilator, coronary
0,077  0,053  Estrogen receptor alpha antagonist
0,117  0,093  Interleukin 1 antagonist
0,225  0,202  Antibacterial
0,099  0,077  Monophenol monooxygenase inhibitor
0,048  0,026  Parathyroid hormone antagonist
0,054  0,033  Estrogen agonist
0,074  0,053  Cushing's syndrome treatment
0,064  0,043  Antiemphysemic
0,031  0,011  Hedgehog signaling activator
0,142  0,123  Cardiodepressant
0,100  0,081  Interleukin 1b antagonist
0,023  0,005  Thyroid hormone alpha agonist
0,059  0,042  Bombesin 1 receptor agonist
0,154  0,138  Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor
0,035  0,018  RNA-directed RNA polymerase stimulant
0,034  0,018  Liver X receptor antagonist
0,189  0,174  5 Hydroxytryptamine uptake stimulant
0,112  0,098  Cocaine dependence treatment
0,058  0,044  Ryanodine receptor antagonist
0,047  0,034  Cholesterol esterase inhibitor
0,021  0,007  Thyroid hormone alpha antagonist
0,127  0,116  Carcinogenic
0,158  0,147  Antineoplastic (renal cancer)
0,032  0,022  ATP citrate lysase inhibitor
0,128  0,118  Liver fibrosis treatment
0,033  0,024  Melatonin receptor 1A agonist
0,059  0,050  Nitric oxide donor
0,202  0,195  FMO1 substrate
0,055  0,048  Androgen agonist
0,121  0,114  CC chemokine 6 receptor antagonist
0,020  0,013  Follicle-stimulating hormone antagonist
0,078  0,073  Estrogen-related receptor beta agonist
0,050  0,044  Postmenopausal disorders treatment
0,048  0,042  Anesthetic inhalation
0,019  0,014  5-Alpha-reductase 2 inhibitor
0,022  0,016  Vitamin D receptor antagonist
0,081  0,077  Contraceptive male
0,049  0,045  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,054  0,049  Pregnane X receptor antagonist
0,060  0,057  Uterine relaxant
0,129  0,125  Antipruritic
0,032  0,029  Tubulin agonist
0,040  0,037  Geranyltranstransferase inhibitor
0,042  0,040  Adenylate cyclase 1 inhibitor
0,104  0,102  Alcohol dehydrogenase substrate
0,096  0,095  Beta amyloid protein antagonist
0,094  0,093  DNA polymerase I inhibitor
0,127  0,125  Ca2+/calmodulin-dependent protein kinase kinase B inhibitor
0,079  0,078  Potassium channel activator
0,017  0,016  Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor
0,062  0,062  Telomerase inhibitor

